AtheroSpectrum Reveals Novel Macrophage Foam Cell Gene Signatures Associated With Atherosclerotic Cardiovascular Disease Risk

Author:

Li Chuan1ORCID,Qu Lili1ORCID,Matz Alyssa J.1ORCID,Murphy Patrick A.23ORCID,Liu Yongmei4,Manichaikul Ani W.5ORCID,Aguiar Derek6ORCID,Rich Stephen S.5ORCID,Herrington David M.7ORCID,Vu David8,Johnson W. Craig8ORCID,Rotter Jerome I.9ORCID,Post Wendy S.13ORCID,Vella Anthony T.110ORCID,Rodriguez-Oquendo Annabelle2ORCID,Zhou Beiyan110ORCID

Affiliation:

1. Department of Immunology (C.L., L.Q., A.J.M., A.T.V., B.Z.), University of Connecticut, Farmington.

2. Center for Vascular Biology (P.A.M., A.R.-O.), University of Connecticut, Farmington.

3. Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD (P.A.M., W.S.P.).

4. Department of Medicine, Divisions of Cardiology and Neurology, Duke University Medical Center, Durham, NC (Y.L.).

5. Center for Public Health Genomics, Department of Public Health Sciences, University of Virginia, Charlottesville (A.W.M., S.S.R.).

6. Department of Computer Science and Engineering, University of Connecticut, Storrs (D.A.).

7. Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC (D.M.H.).

8. Department of Biostatistics, University of Washington, Seattle (D.V., W.C.J.).

9. Institute for Translational Genomics and Population Sciences, Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA (J.I.R.).

10. School of Medicine, and Institute for Systems Genomics (A.T.V., B.Z.), University of Connecticut, Farmington.

Abstract

Background: Whereas several interventions can effectively lower lipid levels in people at risk for atherosclerotic cardiovascular disease (ASCVD), cardiovascular event risks remain, suggesting an unmet medical need to identify factors contributing to cardiovascular event risk. Monocytes and macrophages play central roles in atherosclerosis, but studies have yet to provide a detailed view of macrophage populations involved in increased ASCVD risk. Methods: A novel macrophage foaming analytics tool, AtheroSpectrum, was developed using 2 quantitative indices depicting lipid metabolism and the inflammatory status of macrophages. A machine learning algorithm was developed to analyze gene expression patterns in the peripheral monocyte transcriptome of MESA participants (Multi-Ethnic Study of Atherosclerosis; set 1; n=911). A list of 30 genes was generated and integrated with traditional risk factors to create an ASCVD risk prediction model (30-gene cardiovascular disease risk score [CR-30]), which was subsequently validated in the remaining MESA participants (set 2; n=228); performance of CR-30 was also tested in 2 independent human atherosclerotic tissue transcriptome data sets (GTEx [Genotype–Tissue Expression] and GSE43292). Results: Using single-cell transcriptomic profiles (GSE97310, GSE116240, GSE97941, and FR-FCM-Z23S), AtheroSpectrum detected 2 distinct programs in plaque macrophages—homeostatic foaming and inflammatory pathogenic foaming—the latter of which was positively associated with severity of atherosclerosis in multiple studies. A pool of 2209 pathogenic foaming genes was extracted and screened to select a subset of 30 genes correlated with cardiovascular event in MESA set 1. A cardiovascular disease risk score model (CR-30) was then developed by incorporating this gene set with traditional variables sensitive to cardiovascular event in MESA set 1 after cross-validation generalizability analysis. The performance of CR-30 was then tested in MESA set 2 ( P =2.60×10 −4 ; area under the receiver operating characteristic curve, 0.742) and 2 independent data sets (GTEx: P =7.32×10 –17 ; area under the receiver operating characteristic curve, 0.664; GSE43292: P =7.04×10 −2 ; area under the receiver operating characteristic curve, 0.633). Model sensitivity tests confirmed the contribution of the 30-gene panel to the prediction model (likelihood ratio test; df =31, P =0.03). Conclusions: Our novel computational program (AtheroSpectrum) identified a specific gene expression profile associated with inflammatory macrophage foam cells. A subset of 30 genes expressed in circulating monocytes jointly contributed to prediction of symptomatic atherosclerotic vascular disease. Incorporating a pathogenic foaming gene set with known risk factors can significantly strengthen the power to predict ASCVD risk. Our programs may facilitate both mechanistic investigations and development of therapeutic and prognostic strategies for ASCVD risk.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3